Anemia of Folate Deficiency

Slide 1 · Anemia of Folate Deficiency

Megaloblastic anemia: metabolism, etiology, morphology and diagnosis

Biochemical mechanism → megaloblastic morphology → differential diagnosis

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Trace folate-dependent one-carbon transfer into DNA synthesis.

Classify causes of deficiency by inadequate supply, increased need and impaired utilization.

Recognize the blood and marrow pattern of megaloblastosis.

Distinguish folate deficiency from vitamin B₁₂ deficiency safely.

Slide 3 · Folate deficiency is a production disorder

Insufficient usable folate

Impaired DNA synthesis

Ineffective hematopoiesis

Megaloblastic anemia

Schematic · causal sequence

Slide 4 · Where folate deficiency fits among anemias

Red-cell underproduction

Nutritional deficiencies are major causes of diminished erythropoiesis.

Megaloblastic pattern

DNA synthesis failure produces abnormally large precursors and circulating red cells.

Shared phenotype

Folate and vitamin B₁₂ deficiencies have indistinguishable hematologic morphology.

Slide 5 · Megaloblastosis begins with defective DNA synthesis

Reduced thymidine formation

Delayed nuclear maturation

Cell division impaired

Large developing erythroid cells

Schematic · causal sequence

Slide 6 · One-carbon transfer is folate’s central role

FH₄ accepts one-carbon units

Reduced folate derivatives

Carbon units donated

FH₄ available again

Original schematic of the folate one-carbon carrier cycle.

Slide 7 · Tetrahydrofolate is the metabolic carrier

FH₄ (tetrahydrofolate) accepts one-carbon fragments.

Folate derivatives transfer these fragments to biosynthetic reactions.

The folate pool is recycled through regeneration of FH₄.

Slide 8 · Where the one-carbon fragments originate

Serine

An example donor of one-carbon fragments.

Formiminoglutamic acid

Another donor identified in folate metabolism.

FH₄ pool

Accepts transferred fragments for subsequent biosynthesis.

Slide 9 · Three major folate-dependent processes

Purine synthesis

Supplies essential components of nucleic acids.

Methionine synthesis

Homocysteine → methionine; Also requires vitamin B₁₂.

DTMP synthesis

Produces deoxythymidine monophosphate for DNA.

Slide 10 · Purine synthesis depends on folate transfer

One-carbon folate derivatives

Transfer carbon fragments

Purine nucleotide synthesis

Supports nucleic-acid formation

Schematic · causal sequence

Slide 11 · Methionine synthesis links folate and vitamin B₁₂

N⁵-methyl-FH₄

Methionine synthase + B₁₂

Homocysteine → methionine

Regeneration of FH₄

Schematic · causal sequence

Slide 12 · DTMP synthesis is critical for DNA replication

DUMP substrate

Folates supply carbon unit

DTMP is formed

DNA synthesis can proceed

Schematic · causal sequence

Slide 13 · Thymidylate production changes the folate pool

N⁵,¹⁰-methylene-FH₄

Carbon donation during dTMP synthesis

FH₂ is produced

FH₄ must be regenerated

Schematic · causal sequence

Slide 14 · Dihydrofolate reductase regenerates FH₄

FH₂ (dihydrofolate)

Dihydrofolate reductase

FH₄ (tetrahydrofolate)

Re-enters one-carbon metabolism

Schematic · causal sequence

Slide 15 · Why dihydrofolate reductase matters

Biochemical role

Restores reduced folate after dTMP generation.

Drug vulnerability

Dihydrofolate reductase is sensitive to folate antagonists.

Cellular consequence

Failure of regeneration reduces folate available for DNA synthesis.

Slide 16 · Folate deficiency converges on a single lesion

Folate shortage or antagonism

Reduced dTMP availability

Suppressed DNA synthesis

Megaloblastic change

Schematic · causal sequence

Slide 17 · Nuclear maturation lags behind cytoplasm

Nucleus

DNA-dependent maturation is delayed.

Chromatin stays abnormally immature.

Cytoplasm

Hemoglobin accumulation continues.

Relative maturation progresses.

The mismatch is nuclear–cytoplasmic asynchrony.

Slide 18 · Rapidly dividing tissues are most vulnerable

Bone marrow

Erythroid and granulocytic precursors are affected.

Gastrointestinal epithelium

Rapid turnover increases vulnerability to disrupted synthesis.

Other proliferating cells

Antimetabolite effects are not marrow-restricted.

Slide 19 · Three major etiologic pathways

Decreased availability

Inadequate intake or poor intestinal absorption.

Increased requirements

DNA synthesis demand exceeds available supply.

Impaired utilization

Folate-antagonist interference with the FH₄ pool.

Slide 20 · Dietary inadequacy reduces folate supply

Humans depend on dietary sources of folate.

Most balanced diets contain more than the minimal adult requirement.

Markedly deficient nutrition places individuals at risk.

Slide 21 · Folate-rich food sources

Green vegetables

Lettuce, spinach, asparagus and broccoli are rich sources.

Other plant foods

Examples include lemons, bananas and melons.

Animal sources

Liver contains folate; It as a lesser source.

Slide 22 · Food folate occurs largely as polyglutamates

Food polyglutamates

Intestinal conjugases

Folate monoglutamates

Absorbable forms

Schematic · causal sequence

Slide 23 · Cooking can markedly reduce folate content

Food folylpolyglutamates are sensitive to heating.

Substantial losses with brief boiling, steaming or frying.

Food preparation can alter effective folate intake.

Slide 24 · Proximal jejunum is the absorption site

Dietary folate deconjugation

Proximal jejunal absorption

Modification to 5-methyl-FH₄

Transport in circulation

Schematic · causal sequence

Slide 25 · 5-Methyl-FH₄ is the transport form

Intestinal processing

Absorbed forms undergo metabolic modification.

Circulating form

5-methyltetrahydrofolate serves as the transport form.

Cellular use

Folate is supplied to one-carbon metabolism in tissues.

Slide 26 · Folate reserves are relatively modest

Reduced intake

Small body reserve

Deficiency over weeks to months

Impaired erythropoiesis

Schematic · causal sequence

Slide 27 · Diet and body stores differ from vitamin B₁₂

Folate

Relatively modest body stores.

Deficiency may develop within weeks to months.

Vitamin B₁₂

Large intrahepatic reserves are typical.

Depletion often takes several years.

Different reserve sizes explain different nutritional time courses.

Slide 28 · Who develops inadequate folate intake?

Chronic alcohol use disorder

Deficient nutritional intake is common.

Social deprivation

Markedly inadequate diets may occur.

Advanced age

Poor overall nutrition can contribute.

Slide 29 · Alcohol-associated deficiency is multifactorial

Dietary deficit

Intake may be inadequate.

Abnormal folate handling

Hepatic trapping and increased urinary losses are implicated.

Disturbed metabolism

Cirrhosis and alcohol-related metabolic changes can contribute.

Slide 30 · Folate deficiency may coexist with malnutrition

Chronic alcohol-associated folate deficiency may accompany generalized malnutrition.

Cheilosis, glossitis and dermatitis can reflect other vitamin deficits.

These manifestations do not specifically identify folate deficiency.

Slide 31 · Small-intestinal disease may impair absorption

Sprue

A malabsorption syndrome associated with reduced folate uptake.

Infiltrative disease

Small-intestinal lymphoma is an example in the source.

Underlying principle

Damage to the absorptive intestine reduces availability.

Slide 32 · Medications may interfere with folate absorption

The anticonvulsant phenytoin as interfering with absorption.

Oral contraceptives are also listed in its account.

Medication history belongs in the etiologic assessment.

Slide 33 · Hemodialysis is listed as an increased-loss cause

Category

Increased folate loss.

Example

Hemodialysis appears in the chapter’s etiologic table.

Clinical implication

Nutritional risk assessment should consider loss as well as intake.

Slide 34 · Pregnancy increases folate requirements

Pregnancy

Greater need for DNA synthesis

Usual intake may be insufficient

Relative folate deficiency

Schematic · causal sequence

Slide 35 · Infancy is another high-demand state

Rapid growth

Active cell production

Higher folate requirement

Susceptibility to relative deficiency

Schematic · causal sequence

Slide 36 · Hyperactive hematopoiesis increases need

Chronic hemolytic anemia

Compensatory marrow production

Increased DNA synthesis

Higher folate requirement

Schematic · causal sequence

Slide 37 · Disseminated cancer may increase demand

Disseminated malignancy is listed among high-requirement states.

The teaching mechanism is increased cellular proliferation and DNA synthesis.

Apparent “normal intake” may not satisfy increased metabolic needs.

Slide 38 · Normal intake need not exclude deficiency

Adequate dietary supply

Folate is ingested at ordinary levels.

May be sufficient when demands are baseline.

Raised metabolic demand

Pregnancy, infancy or active hematopoiesis.

Usual supply becomes relatively insufficient.

Interpret intake in relation to requirement, not in isolation.

Slide 39 · Folate antagonists impair utilization

Folate antagonist exposure

Inhibition of folate recycling

Reduced metabolically active FH₄

Disrupted DNA synthesis

Schematic · causal sequence

Slide 40 · Methotrexate inhibits dihydrofolate reductase

Methotrexate

Dihydrofolate reductase inhibition

Depleted usable FH₄

Megaloblastic changes in proliferating tissue

Schematic · causal sequence

Slide 41 · Not all drug-related megaloblastosis is folate lack

Direct folate antagonism

Interferes with folate-dependent reactions.

Methotrexate is the source example.

Other DNA-directed drugs

Damage DNA or suppress synthesis by other routes.

Can also create megaloblastic changes.

Morphology reflects disrupted DNA synthesis, not a unique exposure.

Slide 42 · The peripheral smear shows macro-ovalocytes

Diagnostic interpretation

Large oval red cells are characteristic.

Central pallor is often inconspicuous.

This is a conceptual cell drawing, not a photomicrograph.

Schematic — original editable drawing; Not a clinical specimen

Slide 43 · Macrocytes can appear “hyperchromic”

Apparent color

Large cells contain ample hemoglobin.

Many lack central pallor.

MCHC interpretation

Mean cell hemoglobin concentration is not increased.

Appearance should not be confused with true hyperchromia.

Source distinction: Visual appearance is not equivalent to increased MCHC.

Slide 44 · Anisocytosis and poikilocytosis are common

Diagnostic interpretation

Anisocytosis: Variation in erythrocyte size.

Poikilocytosis: Variation in erythrocyte shape.

Large oval forms supply an important morphologic clue.

Schematic — original editable drawing; Not a clinical specimen

Slide 45 · Hypersegmented neutrophils support megaloblastosis

Diagnostic interpretation

Neutrophil nuclei show excessive segmentation.

Five or more nuclear lobes are described.

This is a schematic, not a patient blood smear.

Schematic — original editable drawing; Not a clinical specimen

Slide 46 · Reticulocytes are low despite marrow proliferation

Severe defective DNA synthesis

Intramedullary precursor loss

Ineffective blood-cell production

Low circulating reticulocytes

Schematic · causal sequence

Slide 47 · The bone marrow is usually hypercellular

Anemia

Increased erythropoietic drive

Expansion of precursors

Hypercellular marrow

Schematic · causal sequence

Slide 48 · Megaloblasts retain immature chromatin

Fine nuclear chromatin

Diagnostic interpretation

Erythroid precursors become enlarged.

Nuclei retain fine, immature chromatin.

Morphology reflects delayed nuclear maturation.

Schematic — original editable drawing; Not a clinical specimen

Slide 49 · Nuclear–cytoplasmic asynchrony

Immature nucleus

Hemoglobinized

Cytoplasm

Diagnostic interpretation

Cytoplasmic hemoglobinization advances.

Nuclear condensation lags behind.

Later erythroblasts retain nonpyknotic nuclei.

Schematic — original editable drawing; Not a clinical specimen

Slide 50 · Granulocyte precursors are also dysmature

Giant metamyelocytes

Enlarged maturing myeloid cells.

Giant band forms

Granulocytic nuclear development is abnormal.

Shared cause

DNA synthesis failure affects multiple proliferating lineages.

Slide 51 · Megakaryocytes may be abnormal

Source morphology includes unusually large megakaryocytes.

Nuclear shapes may be bizarre or multilobate.

The multilinage pattern supports a broad DNA maturation defect.

Slide 52 · Ineffective hematopoiesis drives cytopenias

Hypercellular, proliferating marrow

Precursor apoptosis in marrow

Low effective cell output

Anemia ± other cytopenias

Schematic · causal sequence

Slide 53 · Pancytopenia can occur

Red cells

Megaloblastic anemia is central.

White cells

Leukopenia may coexist.

Platelets

Reduction may accompany ineffective multilineage production.

Slide 54 · Folate and B₁₂ deficiency look alike on morphology

Folate deficiency

Macro-ovalocytes and hypersegmented neutrophils.

Megaloblastic marrow changes.

Vitamin B₁₂ deficiency

Same peripheral blood pattern.

Same dysmaturation in marrow.

Morphology establishes megaloblastosis, not the deficient vitamin.

Slide 55 · Folate measurement distinguishes the deficiency

Folate deficiency requires biochemical evidence of reduced folate availability.

Decreased serum or red-cell folate as diagnostic support.

Morphology alone cannot separate folate and vitamin B₁₂ deficiency.

Slide 56 · Homocysteine rises in both deficiencies

Folate deficiency

Homocysteine is increased.

Folate is needed for the methionine reaction.

Vitamin B₁₂ deficiency

Homocysteine is also increased.

Methionine synthase requires cobalamin.

High homocysteine does not by itself identify the deficient vitamin.

Slide 57 · Methylmalonate helps distinguish B₁₂ deficiency

Folate deficiency

Methylmalonate concentration is normal.

No direct block in the B₁₂-dependent mutase reaction.

Vitamin B₁₂ deficiency

Methylmalonate is increased.

Cobalamin-dependent metabolism is impaired.

Interpret markers in context of vitamin assays and the clinical picture.

Slide 58 · Neurologic deficits distinguish the classic syndromes

Folate deficiency

Neurologic changes do not occur.

Hematologic features can be severe.

Vitamin B₁₂ deficiency

Neurologic injury may accompany anemia.

Spinal cord and peripheral nerve dysfunction can occur.

Folate replacement does not treat neurologic injury from B₁₂ deficiency.

Slide 59 · Do not treat megaloblastosis blindly with folate

Megaloblastic anemia suspected

Evaluate vitamin B₁₂ deficiency

Identify deficient factor

Give appropriate replacement

Schematic · causal sequence

Slide 60 · Folate can mask vitamin B₁₂ deficiency anemia

Folate administration can improve the blood counts even when B₁₂ is deficient.

Hematologic correction does not protect against B₁₂-related neurologic deficits.

Exclude vitamin B₁₂ deficiency before folate-only treatment.

Slide 61 · Reticulocytosis indicates hematologic response

Confirmed folate deficiency

Folic acid replacement

Prompt reticulocyte response

Recovery of effective erythropoiesis

Schematic · causal sequence

Slide 62 · Diagnostic reasoning: From pattern to cause

Macrocytic/megaloblastic pattern

Review diet, demand, intestinal disease and drugs

Measure folate and assess B₁₂

Interpret homocysteine + methylmalonate

Correct cause; Avoid overlooking B₁₂ deficiency

Slide 63 · Case: Inadequate nutrition and alcohol use

An adult with prolonged poor nutrition and chronic alcohol use develops macro-ovalocytes and hypersegmented neutrophils.

What mechanisms of folate depletion should the clinician investigate?

Inadequate dietary folate.

Altered hepatic handling and urinary loss may contribute.

Assess other deficiencies and B₁₂ before folate alone.

Slide 64 · Case: High erythropoietic demand

A patient with chronic hemolytic anemia has increased marrow activity but ordinary dietary folate intake.

Why can folate deficiency still develop?

Sustained erythropoiesis raises DNA synthesis requirements.

The usual intake may be relatively inadequate.

Slide 65 · Case: Antimetabolite-associated marrow changes

A patient receiving methotrexate develops megaloblastic marrow changes and cytopenias.

Which biochemical step is directly targeted?

Dihydrofolate reductase is inhibited.

Active FH₄ regeneration is impaired.

Folate-dependent DNA synthesis becomes deficient.

Slide 66 · Case: Exclude an occult B₁₂ deficiency

A patient has macro-ovalocytes, high homocysteine and megaloblastic marrow changes. Vitamin B₁₂ status is unknown.

Is isolated folate therapy sufficient at this stage?

No: Findings may arise from either deficiency.

Evaluate vitamin B₁₂ and methylmalonate before folate-only therapy.

Slide 67 · A compact biochemical comparison

Feature

Folate deficiency

Vitamin B₁₂ deficiency

Megaloblastic morphology

Present

Present

Homocysteine

Increased

Increased

Methylmalonate

Normal

Increased

Classic neurologic effects

Absent

May occur

Response of anemia to folate

Yes

Can improve despite B₁₂ deficit

Slide 68 · Mechanism, morphology and diagnosis connect

Folate pathway disturbance

DNA synthesis defect

Megaloblastic dysmaturation

Folate/B₁₂ biochemical discrimination

Schematic · causal sequence

Slide 69 · Five essential conclusions

The immediate lesion is inadequate DNA synthesis, not defective hemoglobin synthesis.

Impaired folate availability arises from low supply, greater demand or blocked utilization.

Blood and marrow morphology are indistinguishable from vitamin B₁₂ deficiency.

Methylmalonate remains normal in isolated folate deficiency.

Vitamin B₁₂ deficiency must be excluded before folate-only therapy.

Slide 70 · Selected textbook references

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th ed. (2026). Chapter 14, “Anemia of Folate Deficiency,” printed p. 595.

Companion parent section: “Megaloblastic Anemia,” printed pp. 591–592.

Related figure discussions: Fig. 14.18 (folate–cobalamin metabolism) and Fig. 14.19 (one-carbon transfer).